Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type

NCT05477264 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
38
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Won Seog Kim